Drawing for OPTIMIZING CLINICAL TRIALS: CONCEPT TO CONCLUSION

USPTO serial 85335976

OPTIMIZING CLINICAL TRIALS: CONCEPT TO CONCLUSION

Reviewed by CopyMark Law Group

Reg. 4192908Status 710
Filing date
Status date
Registration date
Aug 21, 2012
Examiner
REINHART, MEGHAN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with OPTIMIZING CLINICAL TRIALS: CONCEPT TO CONCLUSION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A. LaVine

JORDAN A. LAVINE FLASTER/GREENBERG P.C.1600 JFK BLVD FL 2PHILADELPHIA, PA 19103-2808UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring software for use in managing data and information in the field of medical clinical trials and research; medical and scientific research, namely, conducting clinical trials; clinical trial protocol development in the nature of developing protocols for medical clinical trials and research; clinical trial planning and management in the nature of assisting with the development of medical clinical trials and research and the management of the data and information generated in medical clinical trials and research; clinical trial randomization and trial supply management in the nature of the management of data and information generated in medical clinical trials and research, for patient tracking and management, for patient randomization and enrollment, for pharmaceutical supply management and dosing, for logistics management, and for material inventory and supply management; clinical trial monitoring and events capture in the nature of the gathering and organizing the information and data generated in medical clinical trials and research; clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research; providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely, clinical trial protocol development, clinical trial planning and management, clinical trial user and learning management, clinical trial randomization and trial supply management, clinical trial monitoring and events capture, and clinical data capture, management and reportingSECTION 8 - CANCELLEDJan 17, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 22, 2019C8..CANCELLED SEC. 8 (6-YR)—
Aug 21, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 7, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 7, 2014COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 21, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 5, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 5, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 1, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 1, 2012ALIEASSIGNED TO LIE—
Apr 11, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 27, 2012RFTPREMOVED FROM TEAS PLUS—
Mar 27, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 26, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 26, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 19, 2011DOCKASSIGNED TO EXAMINER—
Jun 6, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 6, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance